UNSPSC 51392216: Tramazoline

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H17N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SLE31693IV, chemically known as 4,5-dihydro-n-(5,6,7,8-tetrahydro-1-naphthalenyl)-1h-imidazol-2-amine but generally known as tramazoline, which bears US NIH Compound Identifier 5524. European Medicines Agency schedules Tramazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11211MIG. The term TRAMAZOLINE is an International Non-Proprietary Name.

UNSPSC 51392216 Tramazoline is a Commodity code that maps poorly to recent state and local procurement activity. The single recent opportunity in the record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits Naloxone and Safe Drug Deactivation Systems, not Tramazoline. Naloxone is an opioid antagonist used in emergency overdose response; Tramazoline is a nasal decongestant. The county sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building and all shipping included in vendor proposals. Bidders had to meet drug-free workplace certification, E-Verify compliance, workers' compensation and commercial general liability insurance, and potential FEMA compliance requirements including Clean Air Act and Federal Water Pollution Control Act adherence. The contract term was two years with an optional one-year renewal, and the procurement included a three-month probationary termination clause.

The source reflects no broader state and local solicitation activity under this code outside the single Seminole County opportunity. With only one recent posting and a mismatch between the code's nominal scope and the actual procurement, this code shows limited relevant recent activity for business development purposes under its stated UNSPSC classification.